EU Drug Markets: In-depth analysis

EMCDDA and Europol logo

Illicit drugs are big business. They are one of the main profit-generating activities of organised crime and are estimated to represent around one-fifth of global crime proceeds. 'EU Drug Markets: In-depth analysis' is the fourth comprehensive overview of illicit drug markets in the EU by the EMCDDA and Europol and takes a broad view of these markets from production and trafficking, to distribution and use. Designed as a series of modules, each focuses on the market for a particular drug.

Key insights

This resource offers a strategic and top-level summary for policymakers and decision-makers, to support the development and implementation of policies and actions in Europe, based on a robust understanding of the current drug landscape and emerging threats. It also serves practitioners working in the field and is intended to raise awareness among the general public about these issues.

7 March 2024

Read the resource  

Drug modules

Upcoming drug modules

NPS market (2024)
MDMA market (2024)

About EU Drug Markets

'EU Drug Markets: In-depth analysis' is a strategic and action-oriented analysis of the information available on Europe's illicit drug markets. It takes a broad view of these markets from production and trafficking, to distribution and use. It provides a holistic and systemic perspective, capturing key aspects of the wider security and public health consequences of drug markets, as well as the main factors driving change and new threats.

The analysis takes a modular format and each module focuses on the market for a particular drug — thus providing a unique set of essential resources for law enforcement professionals, policymakers, the academic community and indeed for anyone seeking up-to-date information and analysis on drug markets in Europe.

This is the fourth comprehensive overview of illicit drug markets in the EU by the EMCDDA and Europol.

EMPACT: Fighting crime together


The European Multidisciplinary Platform Against Criminal Threats (EMPACT) tackles the most important threats posed by organised and serious international crime affecting the EU. EMPACT strengthens intelligence, strategic and operational cooperation between national authorities, EU institutions and bodies, and international partners. EMPACT runs in four-year cycles focusing on common EU crime priorities. This EU Drug Market analysis was produced by the EMCDDA and Europol with the support of the EU Member States and features in the operational action plans of EMPACT.


The EMCDDA and Europol would like to thank the following for their help and contribution to the production of this analysis:

As well as these, many other people have been involved and while it is not possible to thank everyone personally, we would like to acknowledge those who have given generously of their time to support this work. In particular, thanks are due to the staff of the following organisations for providing supplementary data and information:

  • Belgian Federal Police;
  • Centro de Inteligencia contra el Terrorismo y el Crimen Organizado (CITCO), Spain;
  • Dutch National Police;
  • French National Police;
  • German Federal Police;
  • Mar-Info North and South;
  • Ministry of Interior of the Slovak Republic;
  • Netherlands Forensic Institute;
  • United States Drug Enforcement Administration.

We also thank the experts who have kindly answered the questions of the authors, and all those who have allowed us to reproduce their photos.

Finally, we would like to thank the many individuals and organisations whose research and analysis we have cited.

Data and methodology

The EU Drug Markets modules utilise data from multiple sources. Primarily, this include data and information reported to the EMCDDA and Europol. Global data are sourced from the UNODC and the INCB. Read more >>

Supporting material

The EMCDDA commissions a number of background reports to support the analysis. These will be published here as they become available. 



Previous editions